SCHEMBL13911908

SCHEMBL13911908

Cc1c(NC(C)(C)C)cccc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
KDM4E B2RXH2 2/20 0.53
CASP3 P42574 2/20 0.53
SENP8 Q96LD8 2/20 0.53
SENP7 Q9BQF6 2/20 0.53
SENP6 Q9GZR1 2/20 0.53
HSD17B10 Q99714 1/20 0.53
PPARG P37231 1/20 0.52
NR1H4 Q96RI1 1/20 0.52
CYP2C9 P11712 3/20 0.50
MEN1 O00255 2/20 0.50
LMNA P02545 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
PTGS2 P35354 2/20 0.50
AKR1C3 P42330 2/20 0.50
KMT2A Q03164 2/20 0.50
HIF1A Q16665 2/20 0.50
AKR1B10 O60218 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1906473 0.83 CLCN2 (0.53) RAB9AKDM4EHSD17B10CYP2C9MEN1
SCHEMBL856314 0.79 NPC1 (0.57) NPC1RAB9AKDM4ECASP3SENP8
SCHEMBL10316415 0.79 NPC1 (0.57) NPC1RAB9AKDM4ECASP3SENP8
SCHEMBL14057916 0.79 NPC1 (0.57) NPC1RAB9AKDM4ECASP3SENP8
Tert-Butanol SCHEMBL28858905 0.77 TSHR (0.53) NPC1RAB9AKDM4ECASP3SENP8
SCHEMBL9848863 0.76 NPC1 (0.62) NPC1RAB9AKDM4ECASP3SENP8
SCHEMBL27703149 0.76 TSHR (0.61) NPC1RAB9AKDM4ECASP3SENP8
Benzene SCHEMBL27265959 0.76 TSHR (0.61) NPC1RAB9AKDM4ECASP3SENP8
SCHEMBL756585 0.76 TSHR (0.61) NPC1RAB9AKDM4ECASP3SENP8
SCHEMBL3248129 0.76 NPC1 (0.54) NPC1RAB9AKDM4ECASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8633160-B2 Small molecule inhibitors of PDZ interactions NONO INC. (CA) 2014-01-21 US disclosed
US-20090062213-A1 Small Molecule Inhibitors of PDZ Interactions ARBOR VITA CORPORATION (US) 2009-03-05 US disclosed
US-20090062213-A1 Small Molecule Inhibitors of PDZ Interactions ARBOR VITA CORPORATION (US) 2009-03-05 US disclosed
US-20080227684-A1 Small Molecule Inhibitors of PDZ Interactions NONO INC. (CA) 2008-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062213-A1 Small Molecule Inhibitors of PDZ Interactions PDLIM5, DAB2IP, PSD NPC1 1925/4885RAB9A 1103/4885KDM4E 4235/4885
US-20080227684-A1 Small Molecule Inhibitors of PDZ Interactions PDLIM5, DAB2IP, PSD NPC1 1925/4885RAB9A 1103/4885KDM4E 4235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.